Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Formoterol/Budesonide via Discair in COPD
NCT03028701Phase 4Completed
- Sponsor
- Neutec Group
- Start
- Sep 2015
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of formoterol, budesonide in chronic obstructive pulmonary disease (COPD), sponsored by Neutec Group. Started Sep 2015; status: completed.
02
Drugs
formoterolbudesonide
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT03028701.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03028701.